Antacids – our new study reveals trends, R&D progress, and predicted revenues
Where is the Antacids market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 197-page report provides 33 tables, 60 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antacids market. See how to exploit the opportunities.
Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 2 segmentations of the Antacids market, with forecasts for 3 Dosage Forms, and 3 Distribution Channels, each forecasted at a global and regional level.
Global Antacids Market by Dosage Form
• Tablets
• Liquids
• Others
Global Antacids Market by Distribution Channel
• Retail
• Online
• Hospital
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America:
• US
• Canada
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe
• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific
• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Antacids market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2029.
Leading companies and the potential for market growth
Overall world revenue for Antacids will surpass $6.21 billion in 2019, our work calculates. We predict strong revenue growth through to 2029.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Antacids Market report helps you
In summary, our 253-page report provides you with the following knowledge:
• Revenue forecasts to 2029 for 2 segmentations of the Antacids market, with forecasts for 3 Dosage Forms, and 3 Distribution Channels, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2029 for 6 regional and 21 key national markets – See forecasts for the Antacids market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Antacids market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Antacids Sequencing market and leading companies. You will find data, trends and predictions.
Get our report today the Antacids Market Trends : Revenue Prospects by Dosage Form (Tablets, Liquids, Others), by Distribution Channel (Retail, Online, Hospital) and Geography.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Antacids Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Antacids Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Global Antacids Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players
3. Global Antacids Market Analysis and Forecast, By Dosage form
3.1. Introduction
3.1.1. Global Antacids Market, Annual Growth Rate Comparison, By Dosage form
3.2. Global Antacids Market Size and Forecast, By Dosage form
3.2.1. Tablets
3.2.2. Liquid
3.2.3. Others
3.3. Global Antacids Attractiveness Index, By Dosage form
4. Global Antacids Market Analysis and Forecast, By Distribution channel
4.1. Introduction
4.1.1. Global Antacids Market, Annual Growth Rate Comparison, By Distribution channel
4.1.2. Global Antacids Market Share Comparison, By Distribution channel (2018 & 2029)
4.2. Global Antacids Market Size and Forecast, By Distribution channel
4.2.1. Retail
4.2.2. Online
4.2.3. Hospital
4.3. Global Antacids Attractiveness Index, By Distribution channel
5. Global Antacids Market Analysis and Forecast, By Region
5.1. Introduction
5.1.1. Global Antacids Market, Annual Growth Rate Comparison, By Region
5.1.2. Global Antacids Market Share Comparison, By Region (2018 & 2029)
5.2. Global Antacids Market Size and Forecast, By Region
5.2.1. North America (U.S., Canada)
5.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
5.2.3. Western Europe (UK, France, Germany, Italy, Spain, Nordic, Benelux, RoWE)
5.2.4. Eastern Europe (Russia, Poland, Rest of Eastern Europe)
5.2.5. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
5.2.6. MEA (GCC, South Africa, North Africa, RoMEA)
5.3. Global Antacids Market Attractiveness Index, By Region
6. North America Antacids Market Analysis and Forecast, 2019–2029
6.1. Introduction
6.1.1. North America Antacids Market
6.1.2. North America Antacids Market, Annual Growth Rate Comparison, By Country
6.2. North America Antacids Market Size and Forecast, By Country
6.2.1. The U.S. Antacids Market
6.2.2. Canada Antacids Market
6.3. North America Antacids Market Size and Forecast, By Dosage form
6.4. North America Antacids Market Size and Forecast, By Distribution Channel
6.5. North America Antacids Market Attractiveness Index
6.6. North America Antacids Market Attractiveness Index, By Country
6.7. North America Antacids Market Attractiveness Index, By Dosage form
6.8. North America Antacids Market Attractiveness Index, By Distribution Channel
7. Latin America Antacids Market Analysis and Forecast, 2019–2029
7.1. Introduction
7.1.1. Latin America Antacids Market
7.1.2. Latin America Antacids Market, Annual Growth Rate Comparison, By Country
7.2. Latin America Antacids Market Size and Forecast, By Country
7.2.1. Brazil Antacids Market
7.2.2. Mexico Antacids Market
7.2.3. Rest of Latin America Antacids Market
7.3. Latin America Antacids Market Size and Forecast, By Dosage form
7.4. Latin America Antacids Market Size and Forecast, By Distribution channel
7.5. Latin America Antacids Market Attractiveness Index
7.6. Latin America Antacids Market Attractiveness Index, By Country
7.7. Latin America Antacids Market Attractiveness Index, By Dosage form
7.8. Latin America Antacids Market Attractiveness Index, By Distribution Channel
8. Western Europe Antacids Market Analysis and Forecast, 2019–2029
8.1. Introduction
8.1.1. Western Europe Antacids Market
8.1.2. Western Europe Antacids Market, Annual Growth Rate Comparison, By Country
8.2. Western Europe Antacids Market Size and Forecast, By Country
8.2.1. U.K. Antacids Market
8.2.2. France Antacids Market
8.2.3. Germany Antacids Market
8.2.4. Italy Antacids Market
8.2.5. Spain Antacids Market
8.2.6. Nordic Antacids Market
8.2.7. Benelux Antacids Market
8.2.8. Rest of Western Europe Antacids Market
8.3. Western Europe Antacids Market Size and Forecast, By Dosage form
8.4. Western Europe Antacids Market Size and Forecast, By Distribution channel
8.5. Western Europe Antacids Market Attractiveness Index
8.6. Western Europe Antacids Market Attractiveness Index, By Country
8.7. Western Europe Antacids Market Attractiveness Index, By Dosage form
8.8. Western Europe Antacids Market Attractiveness Index, By Distribution channel
9. Eastern Europe Antacids Market Analysis and Forecast, 2019–2029
9.1. Introduction
9.1.1. Eastern Europe Antacids Market
9.1.2. Eastern Europe Antacids Market, Annual Growth Rate Comparison, By Country
9.2. Eastern Europe Antacids Market Size and Forecast, By Country
9.2.1. Russia Antacids Market
9.2.2. Poland Antacids Market
9.2.3. Rest of Eastern Europe Antacids Market
9.3. Eastern Europe Antacids Market Size and Forecast, By Dosage form
9.4. Eastern Europe Antacids Market Size and Forecast, By Distribution channel
9.5. Eastern Europe Antacids Market Attractiveness Index
9.6. Eastern Europe Antacids Market Attractiveness Index, By Country
9.7. Eastern Europe Antacids Market Attractiveness Index, By Dosage form
9.8. Eastern Europe Antacids Market Attractiveness Index, By Distribution channel
10. Asia Pacific Antacids Market Analysis and Forecast, 2019–2029
10.1. Introduction
10.1.1. Asia Pacific Antacids Market
10.1.2. Asia Pacific Antacids Market, Annual Growth Rate Comparison, By Country
10.2. Asia Pacific Antacids Market Size and Forecast, By Country
10.2.1. China Antacids Market
10.2.2. India Antacids Market
10.2.3. Australia Antacids Market
10.2.4. ASEAN Antacids Market
10.2.5. Japan Antacids Market
10.2.6. Rest of Asia Pacific Antacids Market
10.3. Asia Pacific Antacids Market Size and Forecast, By Dosage form
10.4. Asia Pacific Antacids Market Size and Forecast, By Distribution channel
10.5. Asia Pacific Antacids Market Attractiveness Index
10.6. Asia Pacific Antacids Market Attractiveness Index, By Country
10.7. Asia Pacific Antacids Market Attractiveness Index, By Dosage form
10.8. Asia Pacific Antacids Market Attractiveness Index, By Distribution channel
10.9. Asia Pacific Antacids Market Attractiveness Index, By Disease Area
11. MEA Antacids Market Analysis and Forecast, 2019–2029
11.1. Introduction
11.1.1. MEA Antacids Market
11.1.2. MEA Antacids Market, Annual Growth Rate Comparison, By Country
11.2. MEA Antacids Market Size and Forecast, By Country
11.2.1. GCC Antacids Market
11.2.2. South Africa Antacids Market
11.2.3. North Africa Antacids Market
11.2.4. Rest of MEA Antacids Market
11.3. MEA Antacids Market Size and Forecast, By Dosage form
11.4. MEA Antacids Market Size and Forecast, By Distribution channel
11.5. MEA Antacids Market Attractiveness Index
11.6. MEA Antacids Market Attractiveness Index, By Country
11.7. MEA Antacids Market Attractiveness Index, By Dosage form
11.8. MEA Antacids Market Attractiveness Index, By Distribution Channel
12. Leading Companies in the Antacids Market
12.1. Competition Dashboard
12.2. Company Share Analysis
12.3. Company Profiling of 25 Major Players
12.3.1. Company Overview
12.3.2. Dosage form Offerings
12.3.3. Financial Performance (2016-2018)
12.3.4. Recent Initiatives
12.3.5. Average Gross Margin (2016-2018)
13. Conclusion
14. Glossary
15. List of Figures
15.1. Research design
15.2. Market segmentation & scope
15.3. Value chain analysis
15.4. Porter’s Five Forces
15.5. Market summary
15.6. Market driver analysis (Current & Future Impact)
15.7. Market restraint analysis (Current & Future Impact)
15.8. Global Antacids Market by Dosage form, 2019-2029 (USD million)
15.9. Global Antacids Market for Tablets, 2019-2029 (USD million)
15.10. Global Antacids Market for Liquid, 2019-2029 (USD million)
15.11. Global Antacids Market for Others, 2019-2029 (USD million)
15.12. Global Antacids Market by Distribution channel, 2019-2029 (USD million)
15.13. Global Antacids Market for Retail, 2019-2029 (USD million)
15.14. Global Antacids Market for Online, 2019-2029 (USD million)
15.15. Global Antacids Market for Hospital,2019-2029 (USD million)
15.16. North America Antacids Market by Dosage form, 2019-2029 (USD million)
15.17. North America Antacids Market for Tablets, 2019-2029 (USD million)
15.18. North America Antacids Market for Liquid, 2019-2029 (USD million)
15.19. North America Antacids Market for Others, 2019-2029 (USD million)
15.20. North America Antacids Market by Distribution channel, 2019-2029 (USD million)
15.21. North America Antacids Market for Retail, 2019-2029 (USD million)
15.22. North America Antacids Market for Online, 2019-2029 (USD million)
15.23. North America Antacids Market for Hospital,2019-2029 (USD million)
15.24. Latin America Antacids Market by Dosage form, 2019-2029 (USD million)
15.25. Latin America Antacids Market for Tablets, 2019-2029 (USD million)
15.26. Latin America Antacids Market for Liquid, 2019-2029 (USD million)
15.27. Latin America Antacids Market for Others, 2019-2029 (USD million)
15.28. Latin America Antacids Market by Distribution channel, 2019-2029 (USD million)
15.29. Latin America Antacids Market for Retail, 2019-2029 (USD million)
15.30. Latin America Antacids Market for Online, 2019-2029 (USD million)
15.31. Latin America Antacids Market for Hospital,2019-2029 (USD million)
15.32. Western Europe Antacids Market by Dosage form, 2019-2029 (USD million)
15.33. Western Europe Antacids Market for Tablets, 2019-2029 (USD million)
15.34. Western Europe Antacids Market for Liquid, 2019-2029 (USD million)
15.35. Western Europe Antacids Market for Others, 2019-2029 (USD million)
15.36. Western Europe Antacids Market by Distribution channel, 2019-2029 (USD million)
15.37. Western Europe Antacids Market for Retail, 2019-2029 (USD million)
15.38. Western Europe Antacids Market for Online, 2019-2029 (USD million)
15.39. Western Europe Antacids Market for Hospital,2019-2029 (USD million)
15.40. Eastern Europe Antacids Market by Dosage form, 2019-2029 (USD million)
15.41. Eastern Europe Antacids Market for Tablets, 2019-2029 (USD million)
15.42. Eastern Europe Antacids Market for Liquid, 2019-2029 (USD million)
15.43. Eastern Europe Antacids Market for Others, 2019-2029 (USD million)
15.44. Eastern Europe Antacids Market by Distribution channel, 2019-2029 (USD million)
15.45. Eastern Europe Antacids Market for Retail, 2019-2029 (USD million)
15.46. Eastern Europe Antacids Market for Online, 2019-2029 (USD million)
15.47. Eastern Europe Antacids Market for Hospital,2019-2029 (USD million)
15.48. Asia Pacific Antacids Market by Dosage form, 2019-2029 (USD million)
15.49. Asia Pacific Antacids Market for Tablets, 2019-2029 (USD million)
15.50. Asia Pacific Antacids Market for Liquid, 2019-2029 (USD million)
15.51. Asia Pacific Antacids Market for Others, 2019-2029 (USD million)
15.52. Asia Pacific Antacids Market by Distribution channel, 2019-2029 (USD million)
15.53. Asia Pacific Antacids Market for Retail, 2019-2029 (USD million)
15.54. Asia Pacific Antacids Market for Online, 2019-2029 (USD million)
15.55. Asia Pacific Antacids Market for Hospital,2019-2029 (USD million)
15.56. MEA Antacids Market by Dosage form, 2019-2029 (USD million)
15.57. MEA Antacids Market for Tablets, 2019-2029 (USD million)
15.58. MEA Antacids Market for Liquid, 2019-2029 (USD million)
15.59. MEA Antacids Market for Others, 2019-2029 (USD million)
15.60. MEA Antacids Market by Distribution channel, 2019-2029 (USD million)
15.61. MEA Antacids Market for Retail, 2019-2029 (USD million)
15.62. MEA Antacids Market for Online, 2019-2029 (USD million)
15.63. MEA Antacids Market for Hospital,2019-2029 (USD million)
15.64. List of Companies
List of Tables
16.1. Global Antacids Market, by Dosage form, 2019-2029 (USD million)
16.2. Global Antacids Market, by Distribution channel, 2019-2029 (USD million)
16.3. North America Antacids Market, 2019-2029 (USD million)
16.4. U.S. Antacids Market, 2019-2029 (USD million)
16.5. Canada Antacids Market, 2019-2029 (USD million)
16.6. Latin America Antacids Market, 2019-2029 (USD million)
16.7. Brazil Antacids Market, 2019-2029 (USD million)
16.8. Mexico Antacids Market, 2019-2029 (USD million)
16.9. Rest of Latin America Antacids Market, 2019-2029 (USD million)
16.10. Western Europe Antacids Market, 2019-2029 (USD million)
16.11. UK Antacids Market, 2019-2029 (USD million)
16.12. France Antacids Market, 2019-2029 (USD million)
16.13. Germany Antacids Market, 2019-2029 (USD million)
16.14. Italy Antacids Market, 2019-2029 (USD million)
16.15. Nordic Antacids Market, 2019-2029 (USD million)
16.16. Benelux Antacids Market, 2019-2029 (USD million)
16.17. Rest of Western Europe Antacids Market, 2019-2029 (USD million)
16.18. Eastern Europe Antacids Market, 2019-2029 (USD million)
16.19. Russia Antacids Market, 2019-2029 (USD million)
16.20. Poland Antacids Market, 2019-2029 (USD million)
16.21. Rest of Eastern Europe Antacids Market, 2019-2029 (USD million)
16.22. Asia Pacific Antacids Market, 2019-2029 (USD million)
16.23. Japan Antacids Market, 2019-2029 (USD million)
16.24. India Antacids Market, 2019-2029 (USD million)
16.25. Australia Antacids Market, 2019-2029 (USD million)
16.26. ASEAN Antacids Market, 2019-2029 (USD million)
16.27. China Antacids Market, 2019-2029 (USD million)
16.28. Rest of Asia Pacific Antacids Market, 2019-2029 (USD million)
16.29. MEA Antacids Market, 2019-2029 (USD million)
16.30. South Africa Antacids Market, 2019-2029 (USD million)
16.31. North Africa Antacids Market, 2019-2029 (USD million)
16.32. GCC Antacids Market, 2019-2029 (USD million)
16.33. Rest of MEA Antacids Market, 2019-2029 (USD million)
Bayer AG
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories Ltd.
First Aid Only
GlaxoSmithKline plc
Johnson & Johnson
Pfizer Inc.
Private Lable
Procter & Gamble
Reckitt Benckiser Group plc
Sanofi-Aventis LLC
Sun Pharmaceuticals Ltd.
Takeda Pharmaceutical Company Limited
WellSpring Pharm